1. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials 
Jochen Schmitt, MD, Phyllis I. Spuls, MD, PhD, Kim S. Thomas, PhD, Eric Simpson, MD, Masutaka Furue, MD, Stefanie Deckert, MPH, Magdalene Dohil, MD, Christian Apfelbacher, PhD, Jasvinder A. Singh, MD, Joanne Chalmers, PhD, Hywel C. Williams, DSc 
Journal of Allergy and Clinical Immunology 
Volume 134, Issue 4, Pages (October 2014)
DOI: /j.jaci
Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Fig 1
HOME roadmap to identify adequate instruments to measure a specific core domain for AE trials. Core outcome domains are as follows: (1) clinical signs, (2) symptoms, (3) quality of life, and (4) long-term control of flares.
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions